الملخص الإنجليزي
Objectives: Patients with end-stage renal disease (ESRD) are known to experience
poorer quality of life (QoL). The present study aimed to evaluate the effects of
psychotherapy on QoL among patients with ESRD. Methods: We conducted a
systematic search for studies in Medline, PubMed, and SAGE Journals databases
from their dates of inception up to 10 April 2020. The inclusion criteria were studies
on patients with ESRD, of randomized controlled trial design, published in English
language, and with full-text content available online. Two researchers independently
extracted articles that met the selection criteria and evaluated the quality of each study.
A random-effects meta-analysis was conducted, and data was presented in weighted
mean difference (WMD) with a 95% CI. Results: Eight studies were included in the
systematic review of which five were entered for meta-analysis. Compared with the
control group, the intervention group showed a significant enhancement in QoL, in both
physical component summary (PCS) (WMD = 2.52, 95% CI: 0.48–4.57) and mental
component summary (MCS) (WMD = 4.22, 95% CI: 1.54–6.89). The heterogeneity
across studies for both PCS and MCS was found to be I2
= 0%. Conclusions: The
findings indicate that psychotherapy may improve the QoL of patients with ESRD, as
compared to the control group. Therefore, psychotherapy can be considered an essential
component in the management of ESRD patients for improved psychological and
physical outcomes
